Mitral Regurgitation clinical trials

Explore recruiting mitral regurgitation clinical trials.

Recruiting mitral regurgitation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mitral Regurgitation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial)

Poland

Phase III and phase IV (Integrated) EU CTIS Study details

(ASK-CHF2-CS201) A Phase 2, adaptive, double-blinded, placebo-controlled, randomized, multi-center trial to evaluate the efficacy, safety and tolerability of intracoronary infusion of AB-1002 in adult subjects with New York Heart Association (NYHA) Class III heart failure and non-ischemic cardiomyopathy

Austria, Spain, Germany, Netherlands, Hungary, Belgium +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Sacubitril-Valsartan in Heart Failure with Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation (PRAISE-MR)

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 18 years) with Symptomatic Obstructive Hypertrophic Cardiomyopathy (SCOUT-HCM)

Germany, Spain, Italy, Ireland, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mitral Regurgitation trials by city

Mitral Regurgitation in Toronto Mitral Regurgitation in Vancouver Mitral Regurgitation in Montreal Mitral Regurgitation in Calgary Mitral Regurgitation in Edmonton Mitral Regurgitation in Ottawa Mitral Regurgitation in Winnipeg Mitral Regurgitation in Quebec City Mitral Regurgitation in Hamilton Mitral Regurgitation in Kitchener Mitral Regurgitation in London Mitral Regurgitation in Halifax Mitral Regurgitation in New York Mitral Regurgitation in Los Angeles Mitral Regurgitation in Chicago Mitral Regurgitation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease